Pantoprazole sodium hydrate
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-17507B-500 mg |
| CAS # | 164579-32-2 |
| Pricing | 500 mg, USD $180.0 |
| Synonyms | BY1023 sodium hydrate; SKF96022 sodium hydrate |
| MWt | 432.37 |
| Formula | C₁₆H₁₇F₂N₃NaO₅.₅S |
| Biological Activity | Pantoprazole sodium hydrate (BY10232 sodium hydrate) is an orally active and potent proton pump inhibitor (PPI)[1]. Pantoprazole sodium hydrate, a substituted benzimidazole, is a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole sodium hydrate improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole sodium hydrate significantly increased tumor growth delay combined with Doxorubicin (HY-15142)[3][4]. |
| Purity | 99.94% |